Pharmaterials are delighted to welcome Bruce Lithgow and Charles Adesuyi to the formulation group. Both join from the same CRO where they provided tablet and capsule formulation services for rapid release and modified release products. They add to Pharmaterials strengths in the development of formulations for poorly soluble drug substances and provide our customers with experienced formulators who can offer many possible solutions to formulation issues.
Bruce will manage the Formulation Group, including solid, liquid and inhalation formulation activities. Bruce will also run the Screening Group, an area in which he has considerable expertise from his previous position in RPR.
Dr Chris Kirby, previously Director of Formulation has become Senior Director of Research and will develop the novel technologies within the company and lead the continuous improvement of our services based on research.
David Crowe, an experienced screening scientist, has joined the screening group from GSK, further strengthening the service provision in this area.
Martin Wing-King has joined the Business Development team where he is supporting the inhalation development and formulation programmes in particular. |
